ATE322485T1 - Propan-1,3-dion-derivate - Google Patents

Propan-1,3-dion-derivate

Info

Publication number: ATE322485T1
Authority: AT; Austria
Prior art keywords: propane; dione derivatives; dione derivative; gnrh; dione
Prior art date: 2000-07-05

Application number

AT01949914T

Other languages

English (en)

Inventor

Masaaki Hirano

Eiji Kawaminami

Akira Toyoshima

Hiroyuki Moritomo

Norio Seki

Ryutaro Wakayama

Minoru Okada

Toshiyuki Kusayama

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-05

Filing date

2001-07-04

Publication date

2006-04-15

2001-07-04 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2006-04-15 Application granted granted Critical

2006-04-15 Publication of ATE322485T1 publication Critical patent/ATE322485T1/de

Links

WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical class O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 title abstract 3
NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 abstract 1
102000008238 LHRH Receptors Human genes 0.000 abstract 1
108010021290 LHRH Receptors Proteins 0.000 abstract 1
101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
230000003042 antagnostic effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000002464 receptor antagonist Substances 0.000 abstract 1
229940044551 receptor antagonist Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/84—Naphthothiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT01949914T 2000-07-05 2001-07-04 Propan-1,3-dion-derivate ATE322485T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2000204425		2000-07-05
JP2001153372		2001-05-23

Publications (1)

Publication Number	Publication Date
ATE322485T1 true ATE322485T1 (de)	2006-04-15

Family

ID=26595469

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01949914T ATE322485T1 (de)	2000-07-05	2001-07-04	Propan-1,3-dion-derivate

Country Status (14)

Country	Link
US (2)	US6960591B2 (de)
EP (1)	EP1300398B1 (de)
JP (1)	JP4211394B2 (de)
KR (1)	KR100748294B1 (de)
CN (1)	CN1186326C (de)
AT (1)	ATE322485T1 (de)
AU (2)	AU7102201A (de)
CA (1)	CA2415010C (de)
DE (1)	DE60118564T2 (de)
DK (1)	DK1300398T3 (de)
ES (1)	ES2261437T3 (de)
PL (1)	PL360294A1 (de)
PT (1)	PT1300398E (de)
WO (1)	WO2002002533A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002002533A1 (en) *	2000-07-05	2002-01-10	Yamanouchi Pharmaceutical Co., Ltd.	Propane-1,3-dione derivatives
AUPR213700A0 (en)	2000-12-18	2001-01-25	Biota Scientific Management Pty Ltd	Antiviral agents
SK14512003A3 (sk)	2001-04-30	2004-08-03	Zentaris Gmbh	Spôsob liečenia demencie a neurodegeneratívnych chorôb strednými dávkami LHRH antagonistov
KR101020350B1 (ko) *	2003-03-13	2011-03-08	이데미쓰 고산 가부시키가이샤	신규한 질소 함유 헤테로환 유도체 및 이를 이용한 유기 전기발광 소자
GB0307777D0 (en)	2003-04-04	2003-05-07	Medical Res Council	Conjugate compounds
KR100882366B1 (ko) *	2004-06-04	2009-02-05	아스텔라스세이야쿠 가부시키가이샤	프로판-1,3-디온 유도체 또는 그의 염
CN1964950A (zh) *	2004-06-04	2007-05-16	安斯泰来制药有限公司	丙烷－1,3－二酮衍生物或其盐
UA90894C2 (uk) *	2005-03-31	2010-06-10	Астеллас Фарма Инк	Похідна сполука пропан-1,3-діону або її сіль
EP1864976B1 (de) *	2005-03-31	2012-10-10	Astellas Pharma Inc.	Propan-1,3-dionderivat oder salz davon
AR068509A1 (es) *	2007-09-19	2009-11-18	Jerini Ag	Antagosnistas del receptor de bradiquinina b1
WO2010025375A1 (en)	2008-08-29	2010-03-04	Treventis Corporation	Compositions and methods of treating amyloid disease
EP2448938B9 (de)	2009-06-29	2015-06-10	Incyte Corporation	Pyrimidinone als pi3k-hemmer
AR079529A1 (es) *	2009-12-18	2012-02-01	Incyte Corp	Derivados arilo y heteroarilo sustituidos y fundidos como inhibidores de la pi3k
WO2011075643A1 (en)	2009-12-18	2011-06-23	Incyte Corporation	Substituted heteroaryl fused derivatives as pi3k inhibitors
EP2558463A1 (de)	2010-04-14	2013-02-20	Incyte Corporation	Kondensierte derivate als i3-hemmer
US9062055B2 (en)	2010-06-21	2015-06-23	Incyte Corporation	Fused pyrrole derivatives as PI3K inhibitors
EP2605652B1 (de) *	2010-08-18	2017-11-08	Samumed, LLC	Diketone und hydroxyketone as cateninsignalweg-aktivatoren
TW201249844A (en)	2010-12-20	2012-12-16	Incyte Corp	N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
WO2012125629A1 (en)	2011-03-14	2012-09-20	Incyte Corporation	Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
US9126948B2 (en)	2011-03-25	2015-09-08	Incyte Holdings Corporation	Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
KR102030609B1 (ko)	2011-09-02	2019-10-11	인사이트 홀딩스 코포레이션	Ｐｉ３ｋ 억제제로서 헤테로시클릴아민
AR090548A1 (es)	2012-04-02	2014-11-19	Incyte Corp	Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
ES2709824T3 (es)	2013-02-22	2019-04-17	Samumed Llc	Gamma-dicetonas como activadores de la ruta de señalización Wnt/beta-catenina
US9618507B2 (en)	2014-02-24	2017-04-11	Betanien Hospital	Methods of treating rheumatoid arthritis
WO2015191677A1 (en)	2014-06-11	2015-12-17	Incyte Corporation	Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
DK3206686T3 (da)	2014-08-20	2019-12-16	Samumed Llc	Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker
EP3185881B1 (de) *	2014-08-26	2022-03-09	Betanien Hospital	Verfahren, wirkstoffe und zusammensetzungen zur behandlung von entzündlichen erkrankungen
DK3831833T3 (da)	2015-02-27	2022-11-14	Incyte Holdings Corp	Fremgangsmåder til fremstillingen af en pi3k-inhibitor
WO2016183063A1 (en)	2015-05-11	2016-11-17	Incyte Corporation	Crystalline forms of a pi3k inhibitor
US9732097B2 (en)	2015-05-11	2017-08-15	Incyte Corporation	Process for the synthesis of a phosphoinositide 3-kinase inhibitor
JP6792106B2 (ja) *	2017-03-30	2020-11-25	スピードファム株式会社	ワークキャリア及びワークキャリアの製造方法
EP3634418A1 (de)	2017-06-05	2020-04-15	ObsEva S.A.	Dosierschemata für gonadotropin-freisetzenden hormonantagonisten zur behandlung von endometriose
CN119258070A (zh)	2018-06-01	2025-01-07	因赛特公司	治疗pi3k相关病症的给药方案
WO2020089190A2 (en)	2018-10-29	2020-05-07	ObsEva S.A.	Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis
KR20210100623A (ko)	2018-11-07	2021-08-17	옵스에파 에스에이	에스트로겐-의존성 장애의 치료를 위한 조성물 및 방법
US20220288154A1 (en)	2019-08-08	2022-09-15	ObsEva S.A.	Gnrh antagonists for the treatment of estrogen-dependent disorders
KR20220061120A (ko)	2019-08-08	2022-05-12	옵스에파 에스에이	에스트로겐-의존성 장애 치료용 조성물 및 방법
WO2025155903A1 (en) *	2024-01-19	2025-07-24	Temple University-Of The Commonwealth System Of Higher Education	Compositions of antioxidant translation modulators for treating neurodegenerative disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4062686A (en) *	1976-04-21	1977-12-13	Eastman Kodak Company	Sensitizers for photocrosslinkable polymers
GB8321813D0 (en)	1983-08-12	1983-09-14	Vickers Plc	Radiation sensitive compounds
DE3807381A1 (de)	1988-03-07	1989-09-21	Hoechst Ag	4,6-bis-trichlormethyl-s-triazin-2-ylgruppen enthaltende heterocyclische verbindungen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindung enthaelt
JPH02102401A (ja) *	1988-10-12	1990-04-16	Hitachi Ltd	１次元光センサ用結像装置
US5202221A (en) *	1988-11-11	1993-04-13	Fuji Photo Film Co., Ltd.	Light-sensitive composition
CA2116863A1 (en) *	1992-07-03	1994-01-20	Sumio Yokota	Condensed heterocyclic derivatives and herbicides
JPH0713299A (ja)	1993-06-23	1995-01-17	Fuji Photo Film Co Ltd	ハロゲン化銀写真感光材料
TW449600B (en)	1994-04-19	2001-08-11	Takeda Chemical Industries Ltd	Condensed-ring thiophene derivatives, their production and use
AU3430699A (en)	1998-04-08	1999-11-01	Washington Odur Ayuko	Butenolide derivatives as anti-cancer agents
JP2000095767A (ja)	1998-09-28	2000-04-04	Takeda Chem Ind Ltd	性腺刺激ホルモン放出ホルモン拮抗剤
WO2002002533A1 (en) *	2000-07-05	2002-01-10	Yamanouchi Pharmaceutical Co., Ltd.	Propane-1,3-dione derivatives
SK14512003A3 (sk)	2001-04-30	2004-08-03	Zentaris Gmbh	Spôsob liečenia demencie a neurodegeneratívnych chorôb strednými dávkami LHRH antagonistov

2001
- 2001-07-04 WO PCT/JP2001/005813 patent/WO2002002533A1/ja not_active Ceased
- 2001-07-04 JP JP2002507790A patent/JP4211394B2/ja not_active Expired - Fee Related
- 2001-07-04 DK DK01949914T patent/DK1300398T3/da active
- 2001-07-04 PL PL36029401A patent/PL360294A1/xx unknown
- 2001-07-04 ES ES01949914T patent/ES2261437T3/es not_active Expired - Lifetime
- 2001-07-04 PT PT01949914T patent/PT1300398E/pt unknown
- 2001-07-04 DE DE60118564T patent/DE60118564T2/de not_active Expired - Lifetime
- 2001-07-04 KR KR1020037000111A patent/KR100748294B1/ko not_active Expired - Fee Related
- 2001-07-04 AT AT01949914T patent/ATE322485T1/de active
- 2001-07-04 US US10/311,688 patent/US6960591B2/en not_active Expired - Lifetime
- 2001-07-04 CN CNB01812318XA patent/CN1186326C/zh not_active Expired - Fee Related
- 2001-07-04 AU AU7102201A patent/AU7102201A/xx active Pending
- 2001-07-04 CA CA2415010A patent/CA2415010C/en not_active Expired - Fee Related
- 2001-07-04 EP EP01949914A patent/EP1300398B1/de not_active Expired - Lifetime
- 2001-07-04 AU AU2001271022A patent/AU2001271022B2/en not_active Ceased
2005
- 2005-06-20 US US11/155,595 patent/US7569688B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US20050267110A1 (en)	2005-12-01
KR100748294B1 (ko)	2007-08-09
CN1186326C (zh)	2005-01-26
CA2415010C (en)	2011-05-03
DK1300398T3 (da)	2006-07-17
CA2415010A1 (en)	2002-01-10
DE60118564T2 (de)	2007-01-18
AU2001271022B2 (en)	2006-08-17
PL360294A1 (en)	2004-09-06
US6960591B2 (en)	2005-11-01
PT1300398E (pt)	2006-07-31
DE60118564D1 (de)	2006-05-18
US20030191164A1 (en)	2003-10-09
EP1300398A4 (de)	2004-03-31
WO2002002533A1 (en)	2002-01-10
US7569688B2 (en)	2009-08-04
EP1300398B1 (de)	2006-04-05
EP1300398A1 (de)	2003-04-09
ES2261437T3 (es)	2006-11-16
KR20030019555A (ko)	2003-03-06
JP4211394B2 (ja)	2009-01-21
CN1440391A (zh)	2003-09-03
AU7102201A (en)	2002-01-14

Legal Events

Date

Code

Title

Description

2007-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1300398

Country of ref document: EP

Publication	Publication Date	Title
ATE322485T1 (de)	2006-04-15	Propan-1,3-dion-derivate
NO20034149D0 (no)	2003-09-17	Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
PT1379520E (pt)	2006-08-31	Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
NO20042807L (no)	2004-07-02	Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
NO20041504L (no)	2004-05-13	Lactamderivater som antagonister for humane 11CBY reseptorer.
HN2002000247A (es)	2003-11-24	Derivados de sulfonamida
PT1447399E (pt)	2006-09-29	Derivado de 2-oxo-1-pirrolidina e as suas utilizacoes farmaceuticas
TR200200579T2 (tr)	2002-12-23	Amino-tirazolpiridin türevleri.
HN1999000066A (es)	1999-09-29	Formulaciones farmaceuticas
NO20015477L (no)	2002-01-11	4,5,6,7-tetrahydroindazolderivater som antitumormidler
ITTO20010005A0 (it)	2001-01-09	Formulazione farmaceutica.
PL375874A1 (pl)	2005-12-12	Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
NO20043022L (no)	2004-07-15	5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
NO20042739L (no)	2004-07-23	Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
DK1379522T3 (da)	2005-05-30	Dihydro-benzo(b)(1,4)diazeping-2-on-derivater som MGLUR2-antagonister I
NO20032142D0 (no)	2003-05-13	Substituerte 2-fenylaminoimidazolin-fenylketon-derivater som IP-antagonister
DK1440059T3 (da)	2008-07-14	3-azabicyclo(3.1.0)hexanderivater som opioidreceptorantagonister
ES2187261B2 (es)	2004-07-16	Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
AU2002309038A1 (en)	2003-05-01	Compositions for transmucosal administration containing coenzyme Q as the active ingredient
ATE252377T1 (de)	2003-11-15	Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
IS5730A (is)	2000-11-24	Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni
MA26808A1 (fr)	2004-12-20	Analogues de la vitamine d3.
EA200501697A1 (ru)	2006-06-30	Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
FR2833842B1 (fr)	2004-02-13	Compositions pharmaceutiques a base de derives d'azetidine
DK1406888T3 (da)	2006-09-18	Substituerede gamma-lactonforbindelser som NMDA-antagonister